The White House sought to capitalize on the House descending into chaos by drawing a contrast between Republicans ending Rep. Kevin McCarthy’s (R-CA) speakership and President Joe Biden’s drug pricing program.
But despite 10 drug manufacturers agreeing to negotiate their prices with Medicare, Biden is still struggling to improve public opinion of his economic policies, or Bidenomics.
DESANTIS BEGINS TO TAKE THE GLOVES OFF AGAINST TRUMP
The White House is “gaslighting” the country by misrepresenting its “extortive price setting scheme” as “a negotiation” and “exaggerating potential savings for seniors,” according to Joe Grogan, a domestic policy adviser to former President Donald Trump.
“The big government takeover of this process, which is likely unconstitutional, will put bureaucrats atop a process they are scarcely prepared to run,” Grogan, now a University of South Carolina Schaeffer Center senior fellow, told the Washington Examiner. “Most importantly, it will have far-reaching negative impacts on America’s medical innovation, on which the world depends.”
“Make no mistake, these 10 drug companies didn’t agree to negotiate so much as they were driven by the threat of ruinous civil penalties to participate in a Soviet-style price setting scam,” he said.
President Joe Biden delivers remarks during an event celebrating the Americans wit …